PODD · Insulet Corp
$158.93
-4.79 (-2.93%)
At close · Jul 22
Market Cap
$11.01B
Shares
69.26M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.71B
+30.7%
FY2025
Net Income
$247.1M
-40.9%
FY2025
Gross Margin
71.63%
+1.8pp
FY2025
Operating Margin
17.5%
+2.6pp
FY2025
Diluted EPS
$3.48
-39.8%
FY2025
Operating Cash Flow
$569.3M
+32.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.9B | $2.71B | $2.07B | $1.7B | $1.31B | $1.1B | $904.4M | $738.2M | $563.8M | $463.77M | $366.99M | $263.89M | $231.32M | $185.14M | $211.37M | $152.26M | $96.97M | $66.03M | |
| $22.7M | — | — | — | $9.8M | $500K | $3M | $6.9M | $7.6M | — | — | — | — | — | — | — | — | — | |
| -$14.8M | — | — | — | -$26.7M | -$61.2M | -$45.1M | -$27.7M | -$21.3M | — | — | — | — | — | — | — | — | — | |
| $841M | $768.2M | $625.9M | $537.2M | $499.7M | $346.7M | $322.1M | $257.9M | $193.6M | $186.6M | $155.9M | $130.62M | $104.2M | $95.36M | $119.03M | $85.54M | $53.24M | $47.74M | |
| $2.06B | $1.94B | $1.45B | $1.16B | $805.6M | $752.1M | $582.3M | $480.3M | $370.2M | $277.2M | $211.09M | $133.27M | $127.13M | $89.78M | $92.34M | $66.71M | $43.73M | $18.3M | |
| — | 71.63% | 69.79% | 68.35% | 61.72% | 68.45% | 64.39% | 65.06% | 65.66% | 59.77% | 57.52% | 50.5% | 54.96% | 48.49% | 43.68% | 43.82% | 45.09% | 27.71% | |
| $331.2M | $301.1M | $219.6M | $205M | $180.2M | $160.1M | $146.8M | $132.3M | $94.8M | $75.7M | $55.71M | $43.21M | $27.9M | $21.77M | $24.36M | $21.86M | $16.57M | $13.23M | |
| — | — | — | — | — | — | — | $185.1M | $146.2M | $124.2M | $94.48M | $78.41M | $50.55M | $45.18M | $52.71M | $43.23M | $34.7M | $37.58M | |
| — | — | — | — | — | — | — | $115.5M | $106.1M | $84.7M | $71.6M | $60.39M | $57.55M | $49.51M | $51.24M | $44.08M | $26.67M | $26.84M | |
| $1.22B | $1.17B | $917.2M | $734.8M | $587.8M | $466M | $384M | $298M | $248M | — | — | — | — | — | — | — | — | — | |
| — | $10.5M | $9.8M | $10.2M | $7.2M | $6.8M | $17.4M | $2.7M | $1.8M | $1.2M | $1.2M | $1M | $0 | $4.9M | $6M | $3.9M | $0 | — | |
| — | $90.4M | $80.8M | $72.8M | $63.2M | $57.4M | $55.4M | $27.9M | $15.6M | $13.9M | $13.83M | $15.84M | $12.22M | $11.81M | $11.03M | $8.5M | $5.08M | $5.22M | |
| — | — | — | — | — | — | — | — | $1.1M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | $430.3M | $342.8M | $284.6M | $221.79M | $182.01M | $136M | $116.45M | $128.31M | $109.18M | $82.36M | $77.66M | |
| $507.1M | $473.8M | $308.9M | $220.1M | $37.6M | $126M | $51.5M | $50M | $27.4M | -$7.4M | -$10.7M | -$48.74M | -$8.87M | -$26.68M | -$35.97M | -$42.47M | -$38.63M | -$59.36M | |
| — | 17.5% | 14.91% | 12.97% | 2.88% | 11.47% | 5.69% | 6.77% | 4.86% | -1.6% | -2.92% | -18.47% | -3.84% | -14.41% | -17.02% | -27.89% | -39.84% | -89.89% | |
| — | $564.2M | $389.7M | $292.9M | $100.8M | $183.4M | $106.9M | $77.9M | $43M | $6.5M | $3.13M | -$32.9M | $3.35M | -$14.87M | -$24.94M | -$33.96M | -$33.56M | -$54.14M | |
| $64.9M | $59.4M | $42.7M | $36.2M | $36M | $61.7M | $48.1M | $34.6M | $28.9M | $21.2M | $14.39M | $12.71M | — | — | — | — | — | — | |
| $29.3M | $34.7M | $39.5M | $28.6M | $9.3M | $500K | — | — | — | — | — | — | $129K | $124K | $110K | $139K | $168K | $241K | |
| $17.2M | $14.3M | -$5.5M | $2.2M | -$1.1M | -$1.9M | $3.3M | $900K | -$22.2M | -$19.19M | -$16.11M | -$12.65M | -$39.01M | -$15.78M | -$15.68M | -$14.58M | -$22.53M | -$12.99M | |
| $404.3M | $339.5M | $300.2M | $214.7M | $9.8M | $20.5M | $9.7M | $14.5M | $5.2M | -$26.6M | -$26.82M | -$61.39M | -$47.88M | -$42.46M | -$51.66M | -$57.04M | -$61.16M | -$72.34M | |
| $101.6M | $92.4M | -$118.1M | $8.3M | $5.2M | $3.7M | $2.9M | $2.9M | $1.9M | $200K | $392K | $212K | $60K | $22K | $212K | -$11.21M | — | — | |
| $302.8M | $247.1M | $418.3M | $206.3M | $4.6M | $16.8M | $6.8M | $11.6M | $3.3M | -$26.8M | -$28.88M | -$73.52M | -$51.5M | -$44.97M | -$51.87M | -$45.83M | -$61.16M | -$72.34M | |
| — | 9.12% | 20.19% | 12.16% | 0.35% | 1.53% | 0.75% | 1.57% | 0.59% | -5.78% | -7.87% | -27.86% | -22.26% | -24.29% | -24.54% | -30.1% | -63.07% | -109.56% | |
| $302.8M | $247.1M | $418.3M | $206.3M | $4.6M | $16.8M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $314.4M | $272.8M | $397.1M | $194.4M | $26.8M | $9.1M | $13.5M | $13.3M | $900K | -$26.6M | -$28.95M | -$74.16M | -$51.49M | -$44.99M | — | — | — | — | |
| USD/shares | — | $3.51 | $5.97 | $2.96 | $0.07 | $0.25 | $0.11 | $0.19 | $0.06 | -$0.46 | -$0.48 | — | — | — | — | — | — | — |
| USD/shares | — | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | -$0.46 | -$0.48 | — | — | — | — | — | — | — |
| shares | — | 70.35M | 70.08M | 69.75M | 69.38M | 67.7M | 64.74M | 60.59M | 58.86M | 58M | 57.25M | 56.79M | 55.63M | 54.01M | 47.92M | 46.69M | 39.61M | — |
| shares | — | 71.89M | 73.89M | 73.63M | 69.91M | 68.58M | 65.95M | 62.3M | 61.01M | 58M | 57.25M | 56.79M | 55.63M | 54.01M | 47.92M | 46.69M | 39.61M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $59.6M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.10×
EV/EBIT
—
Medical Devices median 21.00×
P/E (TTM)
37.13×
Medical Devices median 27.41×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $1,953,900,000 | $1,548,200,000 | $1,287,000,000 | $942,300,000 | $738,900,000 | $596,400,000 | $485,100,000 | $391,800,000 |
| Non Us | $754,300,000 | $523,400,000 | $410,100,000 | $363,000,000 | $359,900,000 | $308,000,000 | $253,100,000 | $172,000,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product Omnipod | $2,674,000,000 | $2,032,700,000 | $1,661,100,000 | $1,247,800,000 | $1,011,400,000 | $834,900,000 | $673,500,000 | $495,500,000 |
| U.S. Omnipod | $1,919,800,000 | $1,509,300,000 | $1,251,000,000 | $884,800,000 | $651,500,000 | $526,900,000 | $420,400,000 | $323,500,000 |
| International Omnipod | $754,300,000 | $523,400,000 | $410,100,000 | $363,000,000 | $359,900,000 | $308,000,000 | $253,100,000 | $172,000,000 |
| Drug Delivery | $34,100,000 | $38,900,000 | $36,000,000 | $57,500,000 | $87,400,000 | $69,500,000 | $64,700,000 | $68,300,000 |
Key facts
CIK
1145197
CUSIP
45784P101
13F (30d)
115 filings
112 filers
Visit website
Investor relations